Logo image of TBHC

BRAND HOUSE COLLECTIVE INC/T (TBHC) Stock Fundamental Analysis

NASDAQ:TBHC - Nasdaq - US4974981056 - Common Stock - Currency: USD

1.5  +0.17 (+12.78%)

After market: 1.45 -0.05 (-3.33%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to TBHC. TBHC was compared to 123 industry peers in the Specialty Retail industry. TBHC may be in some trouble as it scores bad on both profitability and health. TBHC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TBHC had negative earnings in the past year.
In the past year TBHC has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: TBHC reported negative net income in multiple years.
TBHC had negative operating cash flow in 4 of the past 5 years.
TBHC Yearly Net Income VS EBIT VS OCF VS FCFTBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

With a Return On Assets value of -11.59%, TBHC is not doing good in the industry: 78.05% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.59%
ROE N/A
ROIC N/A
ROA(3y)-12.31%
ROA(5y)-5.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TBHC Yearly ROA, ROE, ROICTBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

Looking at the Gross Margin, with a value of 26.73%, TBHC is doing worse than 70.73% of the companies in the same industry.
TBHC's Gross Margin has been stable in the last couple of years.
TBHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y0.19%
TBHC Yearly Profit, Operating, Gross MarginsTBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

TBHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TBHC has been increased compared to 1 year ago.
The number of shares outstanding for TBHC has been reduced compared to 5 years ago.
TBHC has a worse debt/assets ratio than last year.
TBHC Yearly Shares OutstandingTBHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
TBHC Yearly Total Debt VS Total AssetsTBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that TBHC is in the distress zone and has some risk of bankruptcy.
TBHC has a Altman-Z score of 0.37. This is in the lower half of the industry: TBHC underperforms 78.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC10.93%
TBHC Yearly LT Debt VS Equity VS FCFTBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.86 indicates that TBHC may have some problems paying its short term obligations.
The Current ratio of TBHC (0.86) is worse than 82.11% of its industry peers.
A Quick Ratio of 0.09 indicates that TBHC may have some problems paying its short term obligations.
TBHC has a worse Quick ratio (0.09) than 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.09
TBHC Yearly Current Assets VS Current LiabilitesTBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for TBHC have decreased by -4.48% in the last year.
The Revenue has decreased by -7.00% in the past year.
Measured over the past years, TBHC shows a decrease in Revenue. The Revenue has been decreasing by -6.08% on average per year.
EPS 1Y (TTM)-4.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.59%
Revenue 1Y (TTM)-7%
Revenue growth 3Y-7.53%
Revenue growth 5Y-6.08%
Sales Q2Q%-11.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25.82%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TBHC Yearly Revenue VS EstimatesTBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
TBHC Yearly EPS VS EstimatesTBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 1 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TBHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TBHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TBHC Price Earnings VS Forward Price EarningsTBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TBHC Per share dataTBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TBHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRAND HOUSE COLLECTIVE INC/T

NASDAQ:TBHC (8/13/2025, 4:16:15 PM)

After market: 1.45 -0.05 (-3.33%)

1.5

+0.17 (+12.78%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-17 2025-06-17/bmo
Earnings (Next)09-03 2025-09-03
Inst Owners12.9%
Inst Owner ChangeN/A
Ins Owners2.47%
Ins Owner ChangeN/A
Market Cap33.69M
Analysts43.33
Price Target1.02 (-32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.45%
Min EPS beat(2)-12.64%
Max EPS beat(2)-10.27%
EPS beat(4)2
Avg EPS beat(4)1.29%
Min EPS beat(4)-12.64%
Max EPS beat(4)16.93%
EPS beat(8)5
Avg EPS beat(8)22.52%
EPS beat(12)5
Avg EPS beat(12)-5.91%
EPS beat(16)7
Avg EPS beat(16)0.88%
Revenue beat(2)0
Avg Revenue beat(2)-4.7%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)-2.74%
Revenue beat(4)2
Avg Revenue beat(4)-1.82%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)1.65%
Revenue beat(8)2
Avg Revenue beat(8)-2.94%
Revenue beat(12)4
Avg Revenue beat(12)-2.21%
Revenue beat(16)5
Avg Revenue beat(16)-2.36%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.4
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS19.19
BVpS-0.72
TBVpS-0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.73%
FCFM N/A
ROA(3y)-12.31%
ROA(5y)-5.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y0.19%
F-Score3
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.75%
Cap/Sales 0.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.09
Altman-Z 0.37
F-Score3
WACC10.93%
ROIC/WACCN/A
Cap/Depr(3y)37.86%
Cap/Depr(5y)37.17%
Cap/Sales(3y)1.06%
Cap/Sales(5y)1.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.59%
EPS Next Y25.82%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7%
Revenue growth 3Y-7.53%
Revenue growth 5Y-6.08%
Sales Q2Q%-11.17%
Revenue Next Year-7.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-362.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-181.06%
OCF growth 3YN/A
OCF growth 5YN/A